Work

New quinazoline-[1,2,4]triazolo[3,4- b ][1,3,4]thiadiazines as inhibitors of EGFR: synthesis, anti-breast cancer evaluation and in silico studies

Year: 2025

Type: article

Abstract: molecular docking investigations using the Discovery Studio 2021 methodology.

Source: RSC Medicinal Chemistry

DOI: 10.1039/d5md00103j

Authors: Mahadev Dattatray Bandgar, Sampath Peddapelli, Ravikumar Kapavarapu, Joshodeep Boruwa, Sridhar Kavela, Sirassu Narsimha

Institution: Chaitanya

Language: English

Topic: Synthesis and Characterization of Heterocyclic Compounds

Subfield: Organic Chemistry

Field: Chemistry

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4412556178

FWCI: 2.891

Cites: 57

Cited by: 10

Related to: 10